Antibacterial properties of lansoprazole alone and in combination with antimicrobial agents against Helicobacter pylori
- PMID: 7673612
- DOI: 10.1097/00004836-199506001-00008
Antibacterial properties of lansoprazole alone and in combination with antimicrobial agents against Helicobacter pylori
Abstract
The activities of various types of anti-ulcer agents against Helicobacter pylori (Hp) strains were determined using an agar dilution method. Among the compounds tested, proton pump inhibitors were found to exhibit significant activity against this organism. The activity of lansoprazole was four times more potent than that of omeprazole and bismuth subsalicylate, with MICs ranging from 1.56 to 25 micrograms/ml. Exposure of Hp to lansoprazole led to extensive loss of viability and suppression of virulence factors such as motility, adhesiveness to epithelial cells, and urease activity. Lansoprazole produced aberrant bacterial morphology characterized by elongation and constriction of the cells and collapse of cell surface structures. The combination of lansoprazole with antimicrobial agents such as penicillins, cephalosporins, macrolides, tetracyclines, aminoglycosides, quinolones, and metronidazole produced an additive or synergistic growth inhibition of Hp.
Similar articles
-
Antibacterial properties of lansoprazole alone and in combination with antimicrobial agents against Helicobacter pylori.Eur J Clin Microbiol Infect Dis. 1995 May;14(5):391-9. doi: 10.1007/BF02114894. Eur J Clin Microbiol Infect Dis. 1995. PMID: 7556227
-
Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori.Antimicrob Agents Chemother. 1991 Mar;35(3):490-6. doi: 10.1128/AAC.35.3.490. Antimicrob Agents Chemother. 1991. PMID: 2039199 Free PMC article.
-
Growth inhibitory and bactericidal activities of lansoprazole compared with those of omeprazole and pantoprazole against Helicobacter pylori.Helicobacter. 1998 Mar;3(1):21-7. doi: 10.1046/j.1523-5378.1998.08024.x. Helicobacter. 1998. PMID: 9546114
-
Adjuvant therapy for Helicobacter pylori eradication: role of lansoprazole in clinical studies.J Clin Gastroenterol. 1995;20 Suppl 1:S28-31. doi: 10.1097/00004836-199506001-00007. J Clin Gastroenterol. 1995. PMID: 7673611 Review.
-
Effect of lansoprazole on Helicobacter pylori.Clin Ther. 1993;15 Suppl B:32-6. Clin Ther. 1993. PMID: 8205593 Review.
Cited by
-
Synergistic Therapies as a Promising Option for the Treatment of Antibiotic-Resistant Helicobacter pylori.Antibiotics (Basel). 2020 Sep 30;9(10):658. doi: 10.3390/antibiotics9100658. Antibiotics (Basel). 2020. PMID: 33007899 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous